Microbial superantigens and exotoxins may further contribute to tumor progression and therapeutic resistance by reinforcing JAK/STAT signaling, particularly STAT3, and reducing CD8+ T-cell-mediated immune surveillance. This evidence concerns the gene STAT3 and neoplasm.